Objective-Transforming growth factor-␤ (TGF-␤) signaling is required for normal vascular development. We aimed to discover the role of TGF-␤ signaling in embryonic smooth muscle cells (SMCs). Methods and Results-We bred mice with smooth muscle (SM) 22␣-Cre and Tgfbr2 flox alleles to generate embryos in which the type II TGF-␤ receptor (TGFBR2; required for TGF-␤ signaling) was deleted in SMCs. Embryos were harvested between embryonic day (E) 9.5 and E18.5 and examined grossly, microscopically, and by histochemical and RNA analyses. SM22␣-Cre ϩ/0 Tgfbr2 flox/flox (knockout [KO]) embryos died before E15.5 with defects that included cardiac outflow tract abnormalities, persistence of the right dorsal aorta, and dilation of the distal aorta. Histological analyses suggested normal expression of SMC differentiation markers in KO aortas; however, RNA analyses showed that SMC differentiation markers were increased in KO cardiac outflow vessels but decreased in the descending aorta. KO aortas had only rare mature elastin deposits and contained abnormal aggregates of extracellular matrix proteins. Expression of several matrix proteins was significantly decreased in KO descending aortas but not in cardiac outflow vessels. Conclusion-TGF-␤ signaling in SMCs controls differentiation, matrix synthesis, and vascular morphogenesis. Effects of TGF-␤ on SMC gene expression appear to differ depending on the location of SMCs in the aorta. (Arterioscler Thromb Vasc Biol. 2012;32:e1-e11.)
I ntracellular signals initiated by transforming growth factor-␤ (TGF-␤) isoforms play major roles in cardiovascular development and in the initiation and progression of cardiovascular diseases. [1] [2] [3] In mice, for example, complete loss of TGF-␤ signaling caused by germ line deletion of Tgfbr2 (which encodes the type 2 TGF-␤ receptor [TGFBR2]) or loss of TGF-␤1 signaling due to germ line deletion of Tgfb1 both cause defective hematopoiesis, abnormal vascular development, and embryonic death in midgestation (E9.5-E12.5). 4, 5 Germ line deletion of the gene encoding TGF-␤2 ligand causes perinatal death due to abnormalities in growth and remodeling of the heart and cardiac outflow vessels. 6, 7 In adult animals and humans, altered TGF-␤ signaling in vascular cells is associated with atherosclerosis, restenosis, and aneurysm formation. 8 -11 However, the precise cellular pathways through which TGF-␤ signaling affects cardiovascular development and disease remain poorly defined.
In vivo Cre/loxP-mediated gene deletion with cell-typespecific promoters is a powerful tool for identifying cellspecific, biologically significant signaling pathways. With this approach, and using mice with conditional Tgfbr2 alleles, [12] [13] [14] we and others investigated the role of TGF-␤ signaling in smooth muscle cells (SMCs). Several years ago, we used mice in which Cre expression is driven by the smooth muscle (SM) 22␣ promoter (expressed primarily in SMCs and cardiomyocytes beginning on E8.0 -E9.5) 15 to delete Tgfbr2. No SM22␣-Cre ϩ/0 Tgfbr2 flox/flox mice were born, revealing that TGF-␤ signaling in SM22␣-expressing cells is required during embryogenesis. 16 Others subsequently reported that SM22␣ Cre ϩ/0 Tgfbr2 flox/flox embryos died between E12.5 and E16.5, with "underdeveloped hearts and brains." 17 A second study reported that SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos (generated with a different SM22␣-Cre ϩ/0 line) survived until E18.5 with: no gross morphological phenotype; incompletely penetrant (50%) cardiac abnor-malities; a low (12%) incidence of descending thoracic aortic aneurysms; and consistent histological abnormalities of the descending thoracic aorta including decreased expression of SM ␣-actin and fibulin-5 and decreased synthesis/accumulation of elastin. 18 Two other groups used mice with Cre expression limited to either neural crest-or mesodermderived SMCs to delete Tgfbr2. 19 -21 Both found abnormalities in cardiac outflow vessels and pharyngeal arch artery (PAA) patterning after deletion of Tgfbr2 in neural crestderived SMCs but differed as to whether SMC differentiation was affected by Tgfbr2 deletion. Only 1 of the 2 groups noted impaired elastin accumulation after deleting Tgfbr2 in SMCs. 21 Here we report gross, microscopic, ultrastructural, and molecular abnormalities in E12.5 to E14.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos generated from the mice with which we discovered the embryonic lethality of this genotype. 16 Our findings confirm and expand roles for TGF-␤ signaling in vascular development and emphasize the role of cell lineage in determining local vascular responses to deletion of Tgfbr2.
Methods

Transgenic Mice
Mice carrying the SM22␣-Cre 22 and ROSA26 Reporter 23 alleles were obtained from Drs Joachim Herz (University of Texas, Southwestern) and Philippe Soriano (Fred Hutchinson Cancer Research Center), respectively. The Tgfbr2 flox allele 12 was from Drs Per Levéen and Stefan Karlsson (Lund University). Experimental mice were generated by mating SM22␣-Cre ϩ/0 Tgfbr2 flox/wt males with Tgfbr2 flox/flox R26R ϩ/ϩ females. Both parental genotypes were maintained in the C57BL/6 background for at least 10 generations. Mice were genotyped by polymerase chain reaction (PCR) of tail DNA, as described. 16 PCR genotyping primers are in Supplemental  Table I , available online at http://atvb.ahajournals.org. All animal protocols were approved by the Institutional Animal Care and Use Committee of the University of Washington.
Embryo Harvests
Embryos from timed pregnancies were obtained by mating mice overnight and assigning embryonic day (E) 0.5 to the morning on which a vaginal plug was observed. Pregnant females were killed by cervical dislocation, and E9.5 to E18.5 embryos were removed, placed in PBS, and examined with the aid of a dissecting microscope. Embryos were judged to be viable if a heartbeat was present. Embryos were genotyped by PCR of DNA extracted from the entire embryo at E9.5 and from the caudal end of the embryo at later time points.
India Ink Injections
India ink (black India 4415, Higgins, Leeds, MA) was injected through finely drawn glass pipettes into the ductus venosus of E13.5 embryos. Ink-injected embryos were fixed in 4% paraformaldehyde and photographed through the dissecting microscope.
␤-Galactosidase Activity
Embryos and yolk sacs were stained with 5-bromo-4-chloro-3indolyl-␤-D-galactopyranoside (X-gal) essentially as described. 24 Briefly, specimens were fixed in 4% paraformaldehyde for 20 to 30 minutes at 4°C, washed in detergent (0.1 mol/L phosphate buffer, 2 mmol/L MgCl 2 , 0.01% Na deoxycholate, 0.02% NP-40), and stained with X-gal (1 mg/mL, Fermentas, Glen Burnie, MD) at 36°C for 2 hours to overnight. Embryos were dehydrated in 100% ethanol, and some were cleared in 1:2 benzyl alcohol:benzyl benzoate. Histological sections of X-gal-stained embryos (E9.5 and E10.5) were counterstained with nuclear fast red (Vector Laboratories, Burlingame, CA).
Histological Analyses
Embryos (E9.5-E14.5) were fixed in 4% paraformaldehyde at 4°C (20 minutes to 3 hours, depending on embryo age) or in Clarke's fixative (1 hour at room temperature), dehydrated, and embedded in paraffin. Sections (5 m thick) were stained with hematoxylin and eosin (H&E), Movat pentachrome, or Hart's stain according to standard protocols.
Immunohistochemistry
Histological sections were stained with primary antibodies to SM ␣-actin (1:1000, Sigma-Aldrich, St Louis, MO), SM22␣ (1:500, Abcam, Cambridge, MA), fibronectin (1:2000, Abcam), tropoelastin (1:400, Abcam), versican (1 g/mL, Chemicon, Billerica, MA), and phospho-Smad2 (#3101, 1:250 dilution, Cell Signaling Technology, Beverly, MA). Isotype-matched control antibodies or nonimmune IgG were used in place of the primary antibody as a control in each experiment. The SM ␣-actin antibody was used with the mouse-onmouse kit (Vector). Before application of the versican antibody, sections were treated with chondroitinase ABC (0.2 U/mL, Northstar BioProducts, East Falmouth, MA). An antigen retrieval step was performed before application of antibodies to SM ␣-actin, SM22␣, fibronectin, and phospho-Smad2 (Antigen Unmasking Solution, citrate-based, 1:100, Vector) with preincubation of sections with 0.1% Triton X-100 for 10 minutes when detecting phospho-Smad2. Bound primary antibodies were detected with biotinylated rabbit anti-goat and goat anti-rabbit antibodies (Vector) or with the antirabbit HRP-DAB Cell and Tissue Staining Kit (R&D Systems, Minneapolis, MN) when detecting phospho-Smad2. Secondary antibodies were detected with the Vectastain Elite or standard ABC kits and Novared substrate (Vector).
RNA Extraction and Quantitation
RNA was extracted from cardiovascular tissues of E10.5, E12.5, and E13.5 embryos. At E10.5, RNA was obtained from the heart tube, which was isolated by severing the sinus venosus caudally and the cardiac outflow tract cranially. At E12.5 and E13.5, the embryonic cardiac outflow tract and vessels were isolated and used as a source of RNA. A separate segment of descending aorta (from the ductus arteriosus to the aorto-iliac bifurcation in controls, and in a similar location in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos) was removed from the same E13.5 embryos and processed separately for RNA. Total RNA was isolated with the MicroElute Total RNA Kit (Omega, Norcross, GA) and treated with DNase I (Fermentas), and RNA concentration was measured using Nanodrop (Thermo Scientific, Waltham, MA). We measured specific mRNA with quantitative reverse transcription-polymerase chain reaction performed with either the Verso 1-Step QRT-PCR Low ROX Kit (Thermo Scientific) and specific probes (Integrated DNA Technologies, Coralville, IA) or with the GoTaq 2-Step RT-qPCR System (based on binding of a fluorescent dye to double-stranded DNA, Promega, Madison, WI). Reactions were run with the 7500 Real-Time PCR System (Applied Biosystems, Carlsbad, CA). The mRNA measured, as well as the primers (Bioneer, Alameda, CA) and probes (Integrated DNA Technologies) used for the quantitative polymerase chain reactions, are listed in Supplemental Table II . Relative expression levels were calculated using the ⌬⌬Ct method, 25 with normalization to the level of glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA in the same samples.
Transmission Electron Microscopy
The heart and attached structures including the outflow vessels and PAA of E13.5 embryos were dissected free, placed in fixative (2% paraformaldehyde, 2.5% EM grade glutaraldehyde, 0.1 mol/L cacodylate buffer with 3.5 mmol/L CaCl 2 pH 7.3) for several days at 4°C. Samples were then washed 3ϫ10 minutes with 0.1 mol/L cacodylate, 0.1 mol/L sucrose and postfixed with 1% osmium tetroxide in 0.1 mol/L cacodylate for 1 hour at room temperature. After three 10-minute washes with distilled water, samples were stained en bloc with 2% aqueous uranyl acetate for 1 hour at room temperature, rinsed with distilled water, dehydrated with a graded series of ethanol, incubated 3 times for 10 minutes each time in absolute ethanol, washed twice for 10 minutes each time with propylene oxide, and then gradually infiltrated with Eponate (Ted Pella, Redding, CA) epoxy as follows: 1:2 (Eponate:propylene oxide) for 1 hour, 1:1 for 1 hour, 2:1 for 1 hour, 100% Eponate for 1 hour, fresh Eponate overnight, and then embedded in fresh Eponate and polymerized for 24 hours at 65°C. One-micron-thick sections were cut of each sample and stained with 1% Toluidine Blue to assist in orientation. Eighty-to 100-nm-thick sections were cut (diamond knife, Reichert Ultracut S) and poststained with 7% aqueous uranyl acetate followed by lead citrate (Reynolds type). Sections were examined and photographed with a JEOL 1200EXII transmission electron microscope (JEOL, Peabody, MA).
Alternatively, small segments (Ϸ1 mm 3 ) containing the heart, outflow vessels, and aortas of E13.5 embryos were fixed in halfstrength Karnovsky fixative (0.1 mol/L cacodylate, 2.5% glutaraldehyde, 2% paraformaldehyde, pH 7.3) containing 0.2% (wt/vol) ruthenium red (Johnson Matthey, London, United Kingdom) for 3 to 4 hours at room temperature. Samples were then rinsed overnight in 0.1 mol/L cacodylate containing 7.5% sucrose and 0.1% ruthenium red and postfixed for 3 hours at room temperature with cacodylatebuffered 1% osmium tetroxide (pH 7.3) containing 0.05% ruthenium red. The samples were then washed in distilled water, stained en bloc with 2% aqueous uranyl acetate for 1 hour at room temperature, and processed through graded alcohols into Eponate as described above. Ultrathin (70-nm) sections were cut on a Reichert Ultracut S using a Diatome diamond knife and collected on 200-mesh copper grids, stained with 2% uranyl acetate in 50% methanol for 10 minutes, followed by 1% lead citrate for 7 minutes. Sections were imaged using a JEOL JEM 1011 transmission electron microscope at 80 kV fitted with a side-mount AMT 2k digital camera (Advanced Microscopy Techniques, Danvers, MA).
Morphometric Analyses
A Leica DM4000B microscope and digital camera (model DFC295) were used to obtain images of H&E-stained transverse sections of E12.5 embryos and SM ␣-actin immunostained transverse sections of E13.5 embryos. The E12.5 images were used to measure the external circumference of the neural tube and the luminal circumference of both the left and right dorsal aortas, all at the level of the carina. The luminal circumference of the distal aorta was also measured on E12.5 transverse sections. These measurements were made more caudally, on sections in which the mainstem bronchi were approximately 400 m apart. The E13.5 images were used to measure the external circumference of the neural tube, as well as the distal aortic wall thickness, wall area, and luminal circumference. These measurements were made on sections in which the mainstem bronchi were approximately 180 m apart. All measurements were made with Image Pro Plus (Media Cybernetics, Bethesda, MD).
Statistical Analyses
The 2 test was used to determine whether embryo genotype frequencies differed significantly from Mendelian predictions. Data from SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and control embryos were compared with the unpaired t test, or with the Mann-Whitney rank-sum test when data were not normally distributed or group variances were unequal. These tests were carried out using the SigmaStat software package (Systat Software, San Jose, CA).
Results
Deletion of Tgfbr2 in Cardiovascular Cells Is Lethal in Midgestation
X-gal staining of E9.5 to E10.5 embryos revealed tissuespecific expression of the SM22␣-Cre allele, similar to the expression pattern of SM22␣ during embryogenesis. 15 At E9.5, Cre-mediated rearrangement of the ROSA-26 locus was evident in the heart tube and outflow tract (not shown). At E10.5, Cre activity was evident in cells within and adjacent to the heart, dorsal aortas, cerebral vessels, distal descending aorta, and PAA ( Figure 1A revealed all 4 possible genotypes, each at the expected Mendelian frequency (Table; PϾ0.1 at all time points). However, the viability of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos declined after E12.5, with no viable SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos after E14.5 ( Figure 1F ). Viability of the other 3 genotypes at E12.5 to E18.5 was 86% to 100%. Except as indicated below, for the remainder of the study, embryos of all 3 nonlethal genotypes were used as controls.
Defects in PAA and Cardiac Outflow Vessel Remodeling in SM22␣-Cre Tgfbr2 flox/flox Embryos
Viable E9.5 to E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos were not growth retarded, judged either by their gross appearance (Figure 2A Figure 3F ). No left ventricular outflow vessel was seen in serial histological sections cut through the hearts of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos (nϭ3 at E12.5 and nϭ5 at E13.5). The incompletely formed ventricular septum (a normal feature in wild-type E13.5 hearts) allowed blood to leave the left ventricle and enter the right-side outflow tract ( Figure 3D ). The single, ventrally positioned cardiac outflow vessel of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox hearts was also evident macroscopically, with no second ventricular outflow vessel seen in the position normally occupied by the left ventricular outflow tract and aortic valve ( Figure 3G and 3H). In live E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, blood that was ejected into the dilated outflow vessel during systole regurgitated from the outflow vessel into the right ventricle during diastole (see videos at http://dL.dropbox.com/u/24979900/ WT.avi [control embryo] and http://dL.dropbox.com/u/ 24979900/KO.avi [SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryo]; please allow videos to load completely before attempting to view).
The single, right-side cardiac outflow vessel present at E12.5 appeared to connect via the left and right sixth PAA to the left and right dorsal aortas, with regression of the left fourth PAA. To investigate further whether the vessels connecting the cardiac outflow to the dorsal aortas in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos derived from the sixth rather than the fourth PAA, we examined serial transverse sections in E12.5 embryos beginning at the carina and continuing cranially to the point at which the left dorsal aorta first connected to a PAA. In control embryos, this connection was easily identified as the sixth PAA and was 250Ϯ54 m from the carina. In SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, this distance was 280Ϯ65 m (nϭ4 -5; Pϭ0.5). Therefore, the vessels connecting the cardiac outflow tract to the dorsal aortas in the SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos appeared to derive from the sixth PAA. We repeated these measurements on sections from E13.5 embryos. In control embryos, the distance from the carina to the left sixth PAA/ductus arteriosus decreased to 68Ϯ29 m. In SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, this distance was greater, 145Ϯ61 m (nϭ4 -5; Pϭ0.04 versus E13.5 controls), providing evidence 
Persistent Right Dorsal Aorta and Displaced Dilated Distal Aorta in SM22␣-Cre Tgfbr2 flox/flox Embryos
In sections of E12.5 control embryos, the right dorsal aorta was, as expected, smaller than the left dorsal aorta ( Figure  4A) , and by E13.5 the right dorsal aorta had regressed ( Figure  4C ). In contrast, in E12.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, the right dorsal aorta was nearly always larger than the left (5 of 6 embryos; Figure 4B) and was significantly larger than the right dorsal aorta of control embryos (circumfer-enceϭ490Ϯ77 versus 308Ϯ60 m for controls; Pϭ0.006; Figure 4I ). All (10 of 10) E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos examined still had 2 dorsal aortas ( Figure 4D ). Caudal to the junction of the dorsal aortas, the single distal aorta of E12.5 control and SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos were of similar size ( Figure 4J ). However, the distal aorta of E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos was dilated (circumferenceϭ720Ϯ140 versus 380Ϯ59 m for controls; Pϭ0.001; Figure 4E -4H and 4J), and in 5 of 7 embryos examined was located either in the midline (2 of 7) or on the right side (3 of 7) of the embryo (compare Figure 4E and 4F). The distal aorta of E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos had larger SM ␣-actin-stained cross-sectional areas and reduced wall thickness compared with distal aorta of control embryos, although these differences fell short of statistical significance (15 600Ϯ1900 versus 12 700Ϯ1900 m 2 ; Pϭ0.07 and 22Ϯ3 versus 27Ϯ4 m respectively; Pϭ0.09).
SMC Phenotype in SM22␣-Cre Tgfbr2 flox/flox Embryos
To begin to define the molecular and cellular mechanisms through which loss of TGF-␤ signaling in SM22␣-expressing cells causes these vascular abnormalities, we examined sections of embryos stained with H&E (for general tissue structure), Movat pentachrome (stains SMCs red, collagen yellow, and proteoglycans blue), or with antibodies that detect SM ␣-actin or SM22␣ proteins (markers of vascular SMC differentiation). H&E-stained sections of E12.5 embryos revealed no differences in the appearance of cells in the walls of the PAA and aortas of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and control embryos (not shown). At E13.5, however, cells in the walls of control aorta were aligned radially with respect to the lumen and were predominantly spindle-shaped, whereas cells in the dorsal and distal aortas of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos often lacked these features (not shown). Movat-stained sections of E13.5 embryos showed these differences well ( Figure 5A-5D ). Moreover, mural cells in large and small arteries of E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos stained less intensely red with Movat stain than their control counterparts, suggesting defective differentiation of mural cells into SMCs. However, immunostaining of E13.5 embryos for SMC differentiation markers SM ␣-actin and SM22␣ proteins showed similar intensity of staining in cardiac outflow vessels and aortas of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and control embryos ( Figures 4E-4H , 5E, and 5F). In addition, transmission electron microscopy (TEM) analysis of outflow vessels and aortas in E13.5 embryos revealed a similar mural cell ultrastructure, including normally appearing endoplasmic reticulum and Golgi apparatus in cells of both groups ( Figure 5G and 5H and data not shown).
To further investigate whether vascular mural cell differentiation to an SMC phenotype was abnormal in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, we measured expression of several markers of SMC differentiation in RNA extracted from the heart tube at E10.5, the cardiac outflow tract and vessels at E12.5 and E13.5, and the descending aorta at E13.5. For these and other gene-expression studies we used RNA from only SM22␣-Cre 0/0 Tgfbr2 flox/flox embryos as a control. In E10.5 heart tubes, although there was not yet a significant decrease in TGFBR2 expression in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos ( Figure 1E ), SM myosin heavy chain mRNA was (surprisingly) modestly increased in these embryos ( Figure 6A ; 30% increase; Pϭ0.04). In E12.5 outflow 
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Arterioscler Thromb Vasc Biol January 2012 tract and vessels of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos (in which TGFBR2 expression was now significantly decreased [ Figure 1E ]), expression of SM myosin heavy chain was again significantly increased ( Figure 6B; 2. 3-fold; PϽ0.001), as was expression of 2 other markers of SMC differentiation: smoothelin and SM22␣ (1.4-fold and 2.3-fold; Pϭ0.04 and Ͻ0.001, respectively). In E13.5 outflow tract and vessels, both SM myosin heavy chain and SM22␣ expression remained significantly elevated ( Figure 6C ; 2-2.5-fold; Pϭ0.03 and 0.007, respectively), and SM ␣-actin expression was also increased (1.7-fold Pϭ0.04). In contrast to this seemingly paradoxical increase in expression of SMC differentiation markers in outflow tract and vessels of both E12.5 and E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, the descending aorta of the same E13.5 embryos contained significantly lower amounts of RNA encoding 3 of the 6 SMC differentiation markers: smoothelin, myocardin, and myosin light chain kinase ( Figure 6D ; 25% to 60% decreases; PՅ0.015 for all). Expression of the other 3 markers (SM ␣-actin, SM myosin heavy chain, and SM22␣) was also decreased in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox aortas (20% to 25%), although these differences were not significant (PՆ0.09 for all).
Extracellular Matrix in SM22␣-Cre Tgfbr2 flox/flox Embryos
Neither H&E-nor Movat-stained sections of E12.5 and E13.5 embryos suggested that extracellular matrix (ECM) accumulation was abnormal in the vasculature of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos. Staining for fibronectin at E13.5 showed only faint positive staining in arteries of both SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and control embryos, with no difference between the groups (not shown). Versican was present in the cardiac outflow tract cushions of embryos of both groups at E12.5 but was absent more distally in the outflow vasculature of both groups (data not shown). Tropoelastin immunostaining of sections of distal aorta (E12.5-E14.5) revealed equivalent staining intensity in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and control embryos (data not shown).
Hart's-stained sections of distal aorta at E14.5 showed fully formed elastic laminas in aorta of control embryos but only small, rare segments of elastin in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos ( Figure 5I and 5J) . We also used TEM to examine E13.5 outflow vessels and aortas, with sampling done at similar locations of the vascular tree of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and control embryos. These analyses revealed less space between mural cells in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox vessels versus mural cells in control vessels, suggestive of decreased matrix accumulation in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox vessels ( Figure 7A and 7B) . Collagen fibers and microfibrils were present in ECM of both groups ( Figure 7C and 7D ). However, although elastin fibers of varying lengths were common in the ECM of control vessels (in both the ascending and the descending aorta; Figure 7C and data not shown), only rare, small segments of elastin were present in ECM of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox outflow vessels and aorta (not shown). TEM of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox aorta also revealed aggregated and disorganized ECM components that stained heavily with ruthenium red, a finding that was absent in the aorta of control embryos ( Figure 7C and 7D and data not shown).
To begin to identify the molecular mechanisms that contribute to abnormal ECM accumulation in arteries of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, we measured expression of RNA encoding several ECM-related proteins. In both E10.5 heart tubes and E12.5 outflow tract and vessels, all ECMrelated RNA were equivalent in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox and controls ( Figure 8A and 8B) . In E13.5 outflow tract vessels, tropoelastin expression was significantly decreased in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos compared with controls ( Figure 8C; 70%; PϽ0.001) , with 8 other ECM-related transcripts present at normal levels. To determine whether tropoelastin expression in E13.5 outflow vessels was decreased in an absolute or only a relative manner, we reanalyzed the tropoelastin PCR data from E10.5, 12.5, and 13.5 with normalization of all data to mean tropoelastin expression Supplemental Table III. in the E10.5 controls ( Figure 8E ). This analysis revealed that tropoelastin expression did increase between E12.5 and E13.5 in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox outflow vessels; however, this 2-fold increase fell far short of the 8-fold increase in wild-type embryos. In contrast to the isolated abnormality in tropoelastin expression in E13.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox outflow vessels, in E13.5 descending aorta from the same embryos, 9 of 12 ECM-related transcripts were significantly decreased in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos ( Figure 8D ; 30%-90% decreases; PՅ0.04 for all 9, with Pϭ0.05 for Col3A1 [26% decrease] and Pϭ0.09 for fibrillin [31% decrease]).
Finally, to assess whether downstream canonical TGF-␤ signaling was altered in SMCs in SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, we stained sections of descending aorta with an antibody to pSmad2 (nϭ4 control; nϭ5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos; all E13.5). The level of staining for SMC nucleus-localized pSmad2 varied among individuals in both groups, with no overall difference between the groups (data not shown).
Discussion
We used Cre/loxP recombination and timed pregnancies to identify developmental defects in embryos with impaired TGF-␤ signaling in SM22␣-expressing cells. We anticipated that examination of these embryos would reveal critical roles played by TGF-␤ signaling during vascular morphogenesis and maturation. Our major findings were as follows: (1) SM22␣-Cre ϩ/0 Tgfbr2 flox/flox mice die between E13.5 and E15.5 with extensive-and likely lethal-cardiovascular abnormalities. (2) The cardiovascular abnormalities include failure to remodel the cardiac outflow tract into 2 separate ventricular outflow vessels, failure to form a competent outflow valve from the right ventricle, agenesis of the left ventricular outflow tract and aortic valve, abnormal regression of the left fourth PAA, persistence of the right sixth PAA and right dorsal aorta, and rightward displacement and dilation of the distal aorta. (3) Impaired TGF-␤ signaling in SM22␣-expressing cells does not prevent cellular differentiation that leads to expression of well-accepted markers of the SMC phenotype. (4) The effects of impaired TGF-␤ signaling on the expression of genes encoding both SMC phenotypic markers and vascular ECM proteins depends on SMC location (and therefore lineage). (5) Impaired TGF-␤ signaling decreases (but does not eliminate) tropoelastin expression and mature elastin assembly (these effects are independent of cell lineage). (6) Impaired TGF-␤ signaling significantly decreases expression of transcripts encoding several ECM proteins and causes abnormal ECM deposition in the aortic wall. Taken together, our data reveal critical lineagedependent and lineage-independent roles for TGF-␤ signaling during embryonic vascular development.
After our initial report of embryonic lethality of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, 16 Carvalho et al 17 reported use of the same SM22␣-Cre and Tgfbr2 flox alleles 12, 26 along with a Tie1-Cre allele 27 to investigate mechanisms of lethality in embryos with impaired vascular TGF-␤ signaling. Deletion of Tgfbr2 in endothelial cells (by Tie1-Cre) phenocopied the complete Tgfbr2 (knockout [KO]), 5 including death at E10.5, whereas SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos survived until at least E12.5. Deaths of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos were attributed to yolk sac vascular insufficiency with growth retardation at E12.5, as well as heart and brain abnormalities that were not described in detail. However, an E12.5 KO embryo from this study ( Figure 2H of Carvalho et al) 17 appears to have a dilated cardiac outflow tract similar to our SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos ( Figure 3B and 3D of this study), suggesting that some phenotypes in the 2 studies may be shared. It is not clear why SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos generated by Carvalho et al differ from ours. A possible explanation is use of a mixed genetic background versus the pure C57BL/6 background used in the present study. Others have found a significant impact of genetic background on the consequences of impaired TGF-␤ signaling in mice. 28 Langlois et al also investigated the consequences of SM22␣-Cre-mediated deletion of Tgfbr2. 18 This group used the same Tgfbr2 flox allele used both by us and by Carvalho et al, 17 a separate Tgfbr2 flox allele 13 (with floxed exon 3 instead of 4), and a newly generated SM22␣-Cre allele. This new SM22␣-Cre allele was active in only a subset of cells in the heart and aorta, with no apparent activity in neural crestderived SMCs of the cardiac outflow vessels or PAA. Accordingly, the SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos have a less severe phenotype than our KO embryos, surviving beyond E18.5 without any defects in cardiac outflow tract septation or PAA remodeling and with a left-side descending aorta. However, as expected based on the presence of Cre activity in the descending aorta, SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos had aortic defects that included occasional dilation, medial thinning and cellular disorganization, patchy loss of SM ␣-actin and tropoelastin immunostaining, and focal absence of medial elastin fibers.
The spatially restricted Cre expression in the SM22␣-Cre ϩ/0 Tgfbr2 flox/flox mice of Langlois et al 18 helps us to interpret the pathogenesis of the descending aortic phenotype of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos in both their study and ours. Based on our study alone, it would not be possible to discern whether abnormalities in the descending aorta were primary (due to deficient TGF-␤ signaling in situ) or secondary (due to abnormal descending aortic hemodynamics caused by proximal outflow tract and PAA abnormalities). However, the presence of a similar descending aortic phenotype to ours in the KO mice of Langlois et al 18 (which lack outflow and PAA abnormalities) suggests strongly that the descending aorta abnormalities found in both studies are due to deficient TGF-␤ signaling in situ. A conclusion that the descending aortic phenotype results from deficient TGF-␤ signaling in situ is also supported by 2 studies in which Tgfbr2 was ablated in neural crest-derived cells (NCCs). 19, 20 Both studies report outflow tract and PAA abnormalities similar to ours, but neither study describes descending aortic abnormalities in embryos examined as late as E17.5 to E18.5.
The presence of robust SM22␣-Cre activity in the cardiac outflow vessels and PAA of our mice ( Figure 1A and 1E ) helped us to uncover more roles of TGF-␤ signaling than are revealed in Langlois et al. 18 Not unexpectedly, some of the outflow tract and PAA abnormalities in our SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos (single cardiac outflow vessel, abnormal regression of the left fourth PAA, dilation of the sixth PAAs) overlap with abnormalities, either in the 2 studies mentioned above, in which a Wnt1-Cre allele is used to disrupt TGF-␤ signaling in NCCs by deletion of Tgfbr2, 19, 20 or in a third study in which the type 1 TGF-␤ receptor ALK5 is deleted in NCCs. 29 Our data therefore confirm a role for TGF-␤ signaling in the contribution of cardiac NCCs to vascular development and identify SM22␣-expressing cells as critical contributors to PAA remodeling and outflow tract septation.
Our data also address conflicts among these earlier studies of TGF-␤ signaling and outflow tract/PAA development. Whereas 1 study attributed failure of outflow tract septation after loss of TGF-␤ signaling in NCCs to failure of NCCs to differentiate to SMCs, 19 another study attributed failure of septation to premature differentiation of NCCs that prevented their organization into the aortopulmonary septum. 20 Our data strongly support the latter study by showing that NCCs that Supplemental Table III. have differentiated toward an SMC phenotype (by expressing SM22␣) are critical contributors to the observed defect. More importantly, we found that disruption of TGF-␤ signaling in these cells increases their expression of several SMC differentiation markers (including SM-myosin heavy chain, SM22␣, smoothelin, and SM ␣-actin). Therefore, TGFBR2 expression by cardiac NCCs seems to retard rather than stimulate their differentiation to SMCs. Premature differentiation of cardiac NCCs that lack TGFBR2 may prevent their organization into the aortopulmonary septum, as suggested (see Figure 4CC and 4FF in Choudhary et al). 20 We considered which of the 3 TGF-␤ isoforms might be responsible for initiating the normal developmental signals that are lost in vascular SMCs of SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos. Protein of all 3 TGF-␤ isoforms is detected in murine vascular SMCs between E12.5 and E18.5, and both TGF-␤2 and -␤3 mRNA are present in the vessel wall of E9.5 to E16 murine embryos. 30, 31 However, data from TGF-␤ isoform-specific KOs implicate TGF-␤2 as the most likely contributor to normal murine vascular development. Mice that lack TGF-␤1 or -␤3 are born without vascular abnormalities, [32] [33] [34] whereas TGF-␤2 KO mice die perinatally with cardiac outflow tract abnormalities that overlap with those reported here. 6 Vascular abnormalities of TGF-␤2 KO mice are less severe and occur later in development compared with our SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos, possibly because of compensation by residual TGF-␤1 and -␤3 in TGF-␤2 KO mice.
Our results shed new light on the mechanisms through which TGF-␤ signaling in SMCs stimulates elastogenesis and guides normal aortic development. Previous studies showed that deletion of Tgfbr2 in arterial SMCs with SM22␣-Cre 18 (or with Wnt1-Cre, Mef2c-Cre, or Dermo1-Cre in a second study) 21 causes both defective elastogenesis and arterial dilation. Both studies attributed arterial dilation to lack of mature elastin, but proposed different mechanisms through which loss of TGF-␤ signaling impairs elastogenesis: lack of fibulin 5 was proposed as a cause of failed elastogenesis in 1 study, 18 and loss of lysyl oxidase activity was proposed in the second. 21 Our results, as well as descriptions of mice with complete deficiency of elastin, 35 fibulin 5, 36, 37 and lysyl oxidase, 38 -40 suggest that neither of these proposed mechanisms is sufficient. First, aortas of elastin-null embryos are indistinguishable from wild-type aortas through E17.5. 35 Therefore, incomplete deficiency of mature elastin fibers cannot account for vessel dilation that begins days earlier. 18, 21 Second, fibulin-5 null mice are born alive with elongated and tortuous-but not dilated-aortas, which contain abundant, although fragmented, elastin. 36 Third, aortas of E18.5 lysyl oxidase-null embryos contain a substantial amount of mature elastin, are narrowed instead of dilated, and contain only focal aneurysms. 38, 39 Therefore, loss of mature elastin, fibulin 5, or lysyl oxidase cannot by itself explain dilation of arteries in which TGF-␤ signaling is reduced in SMCs. Our data suggest an alternative, more comprehensive explanation: both arterial dilation and the near absence of mature medial elastin are caused by decreased expression of several ECM proteins in SMCs with impaired TGF-␤ signaling ( Figure 8D ). Decreased abundance of these proteins and general dysregu-lation of their normally coordinated and time-dependent synthesis likely precludes the normal protein-protein and protein-cell surface interactions on which aortic development and structural integrity depend. 41, 42 According to this model, TGF-␤ signaling stimulates elastogenesis and regulates vessel caliber by upregulating expression of not 1 but several ECM proteins.
Analysis of gene expression in outflow tract/vessels and descending aorta taken from the same E13.5 embryos ( Figure  8C and 8D) yielded a surprising result: loss of Tgfbr2 in these 2 locations has almost completely different effects. This novel result provides in vivo support-in the mammalian vasculature-for the hypothesis that SMC transcriptional responses to TGF-␤ are lineage dependent. 43 The hypothesis that pathways of TGF-␤ signaling in vascular SMCs are lineage dependent was generated to explain why E14 chick aortic SMCs of ectodermal lineage (ie, NCC-derived SMCs from the proximal aorta) respond differently in vitro to TGF-␤ than SMCs of mesodermal lineage (ie, SMCs from the descending aorta). 43 To our knowledge, ours are the first in vivo data that support lineage dependence of SMC responses to TGF-␤. Lineage dependence of TGF-␤-responsiveness appears to apply to a broad range of genes including intracellular SMC lineage markers (SM ␣-actin, SM-myosin heavy chain, and SM22␣), as well as several ECM proteins (lysyl oxidase, lysyl oxidase-like protein 1, fibulin 4, and fibulin 5). In contrast, loss of TGF-␤ signaling decreases tropoelastin expression at both locations, suggesting that TGF-␤ regulation of tropoelastin transcription is lineage independent.
In summary, anatomic and molecular analyses of E12.5 to E14.5 SM22␣-Cre ϩ/0 Tgfbr2 flox/flox embryos provide new insights into the critical roles played by TGF-␤ signaling in SMCs in cardiac outflow tract development, PAA remodeling, ECM synthesis, and aortic development and reveal significant lineage dependence of the SMC transcriptional response to TGF-␤ in vivo.
